You can securely contact [email protected]
And while no major risks have been documented in these studies, some researchers worry about the potential tumor-growth concern mentioned earlier
How Incretin Receptor Agonists Are Transforming Sleep Apnea Management in Adults With Obesity and Diabetes Discover how incretin receptor agonists, including tirzepatide, can improve sleep apnea, reduce CPAP dependence, and enhance health outcomes in adults with obesity and type 2 diabetes
While surgical intervention may offer more rapid relief, it is associated with risks such as significant injury, potential infections, a longer recovery time, and higher costs
Munson, George R
1 Introduction The success and ever increasing interest in incretin-based therapies and drugs especially sitagliptin, vildagliptin and exenatide depict their immense importance in improving patient outcomes in T2DM (Nasr and Sadek, 2022)